FR1120M - Associations médicamenteuses comportant le formaldéhyde sulfoxylate de sodium et le sel sodique de n-(méthylene sulfoxylate) isonicotinoyl hydrazide destinées aux traitements de la tuberculose et de la lepre. - Google Patents

Associations médicamenteuses comportant le formaldéhyde sulfoxylate de sodium et le sel sodique de n-(méthylene sulfoxylate) isonicotinoyl hydrazide destinées aux traitements de la tuberculose et de la lepre.

Info

Publication number
FR1120M
FR1120M FR858382A FR858382A FR1120M FR 1120 M FR1120 M FR 1120M FR 858382 A FR858382 A FR 858382A FR 858382 A FR858382 A FR 858382A FR 1120 M FR1120 M FR 1120M
Authority
FR
France
Prior art keywords
sulfoxylate
leprosy
tuberculosis
methylene
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR858382A
Other languages
English (en)
Inventor
Albert German
Tran Ba Loc
Painvin Nee Yvonne Fremin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PAINVIN
TRAN BA LOC
Original Assignee
PAINVIN
TRAN BA LOC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PAINVIN, TRAN BA LOC filed Critical PAINVIN
Priority to FR858382A priority Critical patent/FR1120M/fr
Application granted granted Critical
Publication of FR1120M publication Critical patent/FR1120M/fr
Priority to GB14030/62A priority patent/GB967133A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/86—Hydrazides; Thio or imino analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR858382A 1961-04-11 1961-04-11 Associations médicamenteuses comportant le formaldéhyde sulfoxylate de sodium et le sel sodique de n-(méthylene sulfoxylate) isonicotinoyl hydrazide destinées aux traitements de la tuberculose et de la lepre. Expired FR1120M (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR858382A FR1120M (fr) 1961-04-11 1961-04-11 Associations médicamenteuses comportant le formaldéhyde sulfoxylate de sodium et le sel sodique de n-(méthylene sulfoxylate) isonicotinoyl hydrazide destinées aux traitements de la tuberculose et de la lepre.
GB14030/62A GB967133A (en) 1961-04-11 1962-04-11 Improvements in or relating to anti-tubercular and anti-leprotic pharmaceutical compositions comprising isonicotinoyl hydrazine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR858382A FR1120M (fr) 1961-04-11 1961-04-11 Associations médicamenteuses comportant le formaldéhyde sulfoxylate de sodium et le sel sodique de n-(méthylene sulfoxylate) isonicotinoyl hydrazide destinées aux traitements de la tuberculose et de la lepre.

Publications (1)

Publication Number Publication Date
FR1120M true FR1120M (fr) 1962-02-12

Family

ID=8752806

Family Applications (1)

Application Number Title Priority Date Filing Date
FR858382A Expired FR1120M (fr) 1961-04-11 1961-04-11 Associations médicamenteuses comportant le formaldéhyde sulfoxylate de sodium et le sel sodique de n-(méthylene sulfoxylate) isonicotinoyl hydrazide destinées aux traitements de la tuberculose et de la lepre.

Country Status (2)

Country Link
FR (1) FR1120M (fr)
GB (1) GB967133A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455234A (en) * 1994-03-16 1995-10-03 Ahluwalia; Gurpreet S. Inhibition of hair growth

Also Published As

Publication number Publication date
GB967133A (en) 1964-08-19

Similar Documents

Publication Publication Date Title
NL148313B (nl) Werkwijze voor de bereiding van therapeutische preparaten, alsmede voor de bereiding van daarvoor geschikte n-gesubstitueerde lactamen.
NL167431C (nl) Werkwijze voor de bereiding van een histaminolytisch werkend preparaat en werkwijze voor de bereiding van een histaminolytisch werkend 4-(1-alkyl-4-piperidyli- deen)benzoŸ4,5ŸcycloheptaŸ1,2-bŸthiofeen
FI46382C (fi) Menetelmä terapeuttisesti arvokkaiden 1-metyyli-2-formyyli- ja 1-metyy li-2-asetyyli-5-nitroimidatsolin semikarbatsonien ja tiosemikarbatsoni en valmistamiseksi.
FR1514M (fr) Nouvelles préparations thérapeutiques.
NL165785B (nl) Werkwijze voor het bereiden van inhibitoren van proteolytische enzymen, alsmede hieruit gevormde therapeutische preparaten.
FR1120M (fr) Associations médicamenteuses comportant le formaldéhyde sulfoxylate de sodium et le sel sodique de n-(méthylene sulfoxylate) isonicotinoyl hydrazide destinées aux traitements de la tuberculose et de la lepre.
FI45660C (fi) Menetelmä terapeuttisesti käytettävien D-6-metyyli- ja D-1,6-dimetyyli -8-aminometyyli-ergoliini I N-asyyli-johdannaisten valmistamiseksi.
FR1121M (fr) Associations médicamenteuses comportant le formaldéhyde sulfoxylate de sodium et l'isoniazide, destinées aux traitements de la tuberculose et de la lepre.
BE618563A (fr) Nouvelles N-(monooxy)-amino-triazines et leur préparation
BE613214A (fr) Nouveaux amides d'acides 1.4-benzodioxanne-carboxyliques et leur préparation
FI49502C (fi) Menetelmä antimidribisesti vaikuttavien N-substituoitujen 1,4-dihydro- 3-karboksi-sykloalkanokinolonien-(4) valmistamiseksi
FR363M (fr) Nouveau médicament pour le traitement des trypanosomoses, des salmonelloses et des infections pénicillo-résistantes.
BE615690A (fr) 3,3-Bis-(4-pyridoyl-amino-phényl)-butane-2-ones et procédés de leur préparation
BE599031A (fr) Agents thérapeutiques dérivés de la morphine et leur préparation.
FR1134M (fr) Médicament constitué par le pyrrolidone carboxylate de choline.
FR1260M (fr) Médicament hépato-protecteur et hépato-régénérateur.
BE611598A (nl) Isonicotinezuurhydrazidederivaat en werkwijze ter bereiding daarvan.
GR21988B (el) Μεθοδος παρασκευης φαρμακευτικου ιδιοσκευασματος κατα του ελκουσδωδεκαδακτυλου, στομαχου και γαστριτιδος.
FR3054M (fr) Préparations pharmaceutiques.
FR2879M (fr) 4,4,14-triméthylpregnenes et lactones d'acides en 21 correspondants.
DK102910C (da) Fremgangsmåde til fremstilling af benzensulfonylurinstoffer og salte heraf.
FR1915M (fr) Nouvel alcaloide et ses dérivés.
BE598428A (fr) Dérivés de benzylguanidines, procédés et préparations pharmaceutiques les contenant
FR3742M (fr) Médicaments nouveaux destinés au traitement de la tuberculose et de la lepre comportant un sel de l'acide isonicotinoyl hydrazine méthane sulfinique.
FR1699M (fr) Nouveau médicament notamment pour le traitement des spasmes d'origine vasculaire et viscérale.